Laura E. Benjamin is listed as an executive officer and director on 1 SEC Form D filing by 1 issuer in Oct 2026: Myris Therapeutics, Inc. (Sharpsburg, PA — biotechnology — 2026; $1.55M reported sold to 8 investors).
What this means One deal on file with the SEC, filed Oct 2026. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
The issuer belongs to the sponsor group Maitri (4 issuers, $27M reported sold, 2017–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Maitri has 4 companies on file and $27M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Laura E. Benjamin and found 2 differences: Form D filed 43 days after the first sale; Same name, different state: "Laura Benjamin" (MA) is a separate record.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.